We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.49B
AUM Growth
+$152M
Cap. Flow
-$14M
Cap. Flow %
-0.4%
Top 10 Hldgs %
22.41%
Holding
361
New
18
Increased
147
Reduced
147
Closed
14

Top Sells

Rank Stock Value
1
LLTC
Linear Technology Corp
LLTC
+$8.75M
2
AGN
Allergan plc
AGN
+$7.3M
3
AFL icon
Aflac
AFL
+$5.62M
4
GILD icon
Gilead Sciences
GILD
+$5.44M
5
ORCL icon
Oracle
ORCL
+$4.24M

Sector Composition

Rank Sector Weight
1 Healthcare 19.72%
2 Technology 15.24%
3 Industrials 10.94%
4 Financials 10.9%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRM icon
26
Iron Mountain
IRM
$36.4B
$40M 1.15%
1,122,357
-40,232
-3% -$1.42M
CVS icon
27
CVS Health
CVS
$133B
$37.1M 1.06%
472,127
-4,853
-1% -$387K
PFE icon
28
Pfizer
PFE
$143B
$35.2M 1.01%
1,084,688
-1,257
-0.1% -$39.6K
MRK icon
29
Merck
MRK
$322B
$35M 1%
576,811
+3,140
+0.5% +$191K
MTD icon
30
Mettler-Toledo International
MTD
$28.6B
$34.6M 0.99%
72,295
-1,150
-2% -$526K
INTC icon
31
Intel
INTC
$455B
$33.8M 0.97%
937,909
+651
+0.1% +$23.6K
NVDA icon
32
NVIDIA
NVDA
$4.86T
$33.3M 0.95%
12,215,080
-1,215,440
-9% -$3.23M
ABBV icon
33
AbbVie
ABBV
$443B
$32.5M 0.93%
498,939
-1,260
-0.3% -$79.2K
CVX icon
34
Chevron
CVX
$392B
$32.4M 0.93%
301,860
+6,165
+2% +$692K
CELG
35
DELISTED
Celgene Corp
CELG
$31.1M 0.89%
250,328
+8,506
+4% +$1.02M
IBM icon
36
IBM
IBM
$211B
$29.9M 0.86%
179,611
-3,955
-2% -$663K
IDXX icon
37
Idexx Laboratories
IDXX
$44.1B
$29.5M 0.84%
190,698
-4,546
-2% -$627K
TJX icon
38
TJX Companies
TJX
$174B
$29.5M 0.84%
745,384
+2,060
+0.3% +$79.4K
ABT icon
39
Abbott
ABT
$183B
$29.3M 0.84%
660,471
+13,448
+2% +$581K
ROP icon
40
Roper Technologies
ROP
$38.8B
$28.9M 0.83%
139,804
+6,107
+5% +$1.22M
ADP icon
41
Automatic Data Processing
ADP
$106B
$28.4M 0.81%
277,078
-1,422
-0.5% -$145K
GSK icon
42
GSK
GSK
$104B
$27.7M 0.79%
525,975
+887
+0.2% +$45K
META icon
43
Meta Platforms (Facebook)
META
$1.42T
$27.2M 0.78%
191,778
+3,422
+2% +$457K
RTN
44
DELISTED
Raytheon Company
RTN
$27M 0.77%
177,062
-1,712
-1% -$258K
PX
45
DELISTED
Praxair Inc
PX
$26.7M 0.77%
225,499
-1,439
-0.6% -$169K
KYN icon
46
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$26.2M 0.75%
1,249,853
-521
-0% -$10.7K
AFL icon
47
Aflac
AFL
$64.9B
$26.1M 0.75%
721,750
-158,640
-18% -$5.62M
GOOGL icon
48
Alphabet (Google) Class A
GOOGL
$4.36T
$25.2M 0.72%
595,140
-7,180
-1% -$302K
STT icon
49
State Street
STT
$50.6B
$24.7M 0.71%
310,526
+7,863
+3% +$624K
BUD icon
50
AB InBev
BUD
$170B
$24.4M 0.7%
221,900
-3,385
-2% -$364K

Similar funds

Welch & Forbes's Q1 2017 Portfolio in Review

As of Q1 2017, Welch & Forbes held 361 positions worth $3.49B, up 4.5% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Welch & Forbes's Q1 2017 filing shows 18 new, 147 increased, 147 reduced and 14 closed positions. Its largest new stake was iShares Russell 1000 Value ETF: 11,269 shares worth $1.3M. The largest sale was Linear Technology Corp, an estimated $8.75M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Welch & Forbes's largest Q1 2017 buy was iShares Russell 1000 Value ETF: 11,269 shares worth $1.3M.
  • Welch & Forbes added most to Franklin Resources in Q1 2017, an estimated $7.71M increase.
  • Welch & Forbes's biggest Q1 2017 reduction was Aflac, cutting an estimated $5.62M.
  • Welch & Forbes fully exited Linear Technology Corp in Q1 2017, selling an estimated $8.75M.
  • Welch & Forbes's ten largest holdings make up 22% of its $3.49B portfolio in Q1 2017.
  • Welch & Forbes opened 18 new positions and closed 14 in Q1 2017.
  • Welch & Forbes's portfolio value rose 4.5% quarter-over-quarter to $3.49B.

Based on Welch & Forbes's 13F filing for Q1 2017, filed 27 Apr 2017.